[{"Assets_0_FY_USD":365086000.0,"CommonStockSharesOutstanding_0_FY_shares":86883300.0,"NetIncomeLoss_4_FY_USD":-141090000.0,"NetIncomeLoss_1_FY_USD":-44659000.0,"StockholdersEquity_0_FY_USD":314877000.0,"EarningsPerShareBasic_4_FY_USD":-1.63,"EarningsPerShareDiluted_4_FY_USD":-1.63,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":86713000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":86713000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170214"}]